PMC:7376974 / 85836-86133 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7376974","sourcedb":"PMC","sourceid":"7376974","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7376974","text":"s-like particles (VLPs) and so to enhance the immunogenicity of the antigens.141 The great advantage of this strategy relies on the easy encapsulation process during the self-assembly making fullerenols versatile for the formulation of different kinds of vaccines. These VLPs were investigated aga","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"1557","span":{"begin":191,"end":202},"obj":"Chemical"}],"attributes":[{"id":"A1557","pred":"tao:has_database_id","subj":"1557","obj":"MESH:C108127"},{"subj":"1557","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T78537","span":{"begin":68,"end":76},"obj":"Chemical"}],"attributes":[{"id":"A58168","pred":"chebi_id","subj":"T78537","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"subj":"T78537","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"2_test","denotations":[{"id":"32667191-23963730-153396","span":{"begin":77,"end":80},"obj":"23963730"}],"attributes":[{"subj":"32667191-23963730-153396","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ec93a2","default":true},{"id":"LitCovid-PD-CHEBI","color":"#93bcec"},{"id":"2_test","color":"#d6ec93"}]}]}}